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Abstract
Study Design: Retrospective chart review.
Introduction: De Quervain’s tenosynovitis is a repetitive stress disorder occurring at the first
dorsal compartment of the wrist at the radial styloid and is commonly treated by hand
therapists.1-3 Conservative treatments include activity modification, modalities, orthotics, and
manual therapy.4-7 The literature is unclear regarding best practice for treating de Quervain’s
tenosynovitis with conservative methods.5,8,9
Purpose of the study: The purpose of this study was to identify which treatment or treatment
combinations was most effective to reduce pain and improve functional outcomes for patients
with de Quervain’s tenosynovitis.
Methods: A retrospective chart review was conducted with 42 patients seen in outpatient therapy.
Patient pain was measured using the Numeric Pain Rating Scale (NPRS) and the QuickDASH
was utilized to assess functional outcomes.10,11
Results: Both iontophoresis with dexamethasone and therapeutic pulsed (20% or 50%)
ultrasound (1.0-1.5 w/cm2) were found to have clinical significance as well as statistical
significance on the QuickDASH (p= 0.028) and NPRS (p= 0.046) respectively. Other treatment
methods were found to be clinically significant but not statistically significant. Demographics of
this sample were reflective of the literature as there were 32 women and 10 men.6 The mean age
of the sample was 39.13 years (range 19-63 years).
Conclusion: This study demonstrated that iontophoresis with dexamethasone may improve
functional outcomes while therapeutic pulsed (20% or 50%) ultrasound (1.0-1.5 w/cm 2 ) may be
effective in decreasing pain in patients with de Quervain’s tenosynovitis.
Level of Evidence: 4.12

TREATMENTS FOR DE QUERVAIN’S TENOSYNOVITIS

3

Introduction
De Quervain’s tenosynovitis is a condition characterized by inflammation at the first
dorsal compartment of the wrist at the radial styloid.2 Inflammation affects the extensor pollicis
brevis (EPB) and abductor pollicis longus (APL) tendons and each of their tendon sheaths and
may result in thickening of the first dorsal extensor sheath. Individuals who perform repetitive
activities of the wrist and hand and who repeatedly use their thumbs in grasping and pinching
motions are most susceptible to de Quervain’s tenosynovitis.3 Population groups at an increased
risk for the development of de Quervain’s tenosynovitis include: women, parents of young
children, and individuals with job tasks that involve repetitive movements of the hand and wrist.6
The main symptom of de Quervain’s tenosynovitis is pain with motions of the wrist or
thumb.13 Decreased abduction of the carpometacarpal joint of the thumb, palpable thickening of
the extensor sheath and of the tendons distal to the extensor tunnel, and crepitus of the tendons
moving through the extensor sheath may also occur.2 Studies have agreed upon diagnostic
criteria for de Quervain’s tenosynovitis including pain or tenderness over the radial side of the
wrist and pain reproduced by resisted thumb extension or abduction. In addition, the
Finkelstein’s test is a physical assessment used to diagnose de Quervain’s tenosynovitis, which is
administered by folding the thumb across the palm and flexing the fingers over the thumb as the
wrist is actively or passively deviated toward the ulnar side.5 A positive test results in localized
pain over the radial styloid and may indicate tenosynovitis of the APL and EPB tendons. Validity
and reliability of this test has been questioned by several authors.6,13-15
De Quervain’s tenosynovitis is one of the most common diagnoses treated by
occupational therapists specializing in hand therapy; therefore, it is imperative that hand/
occupational therapists have knowledge of evidence-based tools and techniques specific to de
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Quervain’s tenosynovitis.1 Conservative occupational therapy treatments for de Quervain’s
tenosynovitis include, but are not limited to, physical agent modalities (i.e. iontophoresis,
ultrasound, and fluidotherapy), activity modification, manual therapy, anti-inflammatory
medications, and a thumb spica or long opponens orthosis.4-7 Although the existing literature
provides information regarding tools and treatment methods, there is no consensus on the
appropriate course of treatment for a patient with de Quervain’s tenosynovitis.5,8 Similarly, there
are no useful evidence-based recommendations for the treatment of de Quervain’s tenosynovitis
as there are no randomized clinical trials available that assess the effectiveness of conservative
treatment with this condition.9 Effective treatment of de Quervain’s tenosynovitis using
fluidotherapy, iontophoresis, and ultrasound therapy is not well supported in the literature, but
these modalities are commonly used in clinical settings. Activity modification is usually
addressed following the diagnosis of de Quervain’s tenosynovitis. Activity or worksite
modifications may include rest, upper extremity orthoses, job and activity modifications, or
physiotherapy.16 Massage, joint manipulation, and joint stabilization techniques are the most
common forms of manual therapy for treating de Quervain’s tenosynovitis.17,18
This retrospective study was a collaboration between a university and a healthcare
organization that explored the effectiveness of conservative hand/occupational therapy
treatments and combination of treatments for individuals diagnosed with de Quervain’s
tenosynovitis. Prior to data collection, this study was approved by two review boards: the
university review board and the healthcare organization review board.
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Purpose of the Study
The purpose of the study was to identify which treatment or treatment combinations was
most effective for patients diagnosed with de Quervain’s tenosynovitis. Effectiveness was
determined by improvement on the QuickDASH and the Numeric Pain Rating Scale (NPRS).10,11
Methods
Design and participants
The researchers, who are graduate occupational therapy students, completed a
retrospective review of 403 electronic medical records and were assisted as needed by clinical
care providers. These records were selected for study from the healthcare organization’s
electronic medical record database for dates of service between January 1, 2009 and January 1,
2013. Following chart selection, the researchers extracted, de-identified, and entered relevant
electronic data into a password protected Excel Extraction Tool Spreadsheet. All identifiable
data were stored on a secure drive only accessible at the healthcare organization. Data collection
occurred from July 2013 to October 2013 and statistical analysis was completed in November
2013. A document was created to link patients to the de-identified data for continued reference.
This document was password protected on a secure server.
Inclusion criteria
The inclusion criteria consisted of the following ICD-9 codes: de Quervain’s
tenosynovitis (727.04), other tenosynovitis of the hand and wrist (727.05), tenosynovitisunspecified (727.00), wrist and hand sprain/strain (842, 842.10), and hand, wrist, and arm pain
(719.44, 719.43, 729.5); additional evidence (i.e. positive Finkelstein’s test) in the electronic
medical record indicating de Quervain's tenosynovitis; also, services must have been provided by
a hand/occupational therapist (Figs. 1 and 2).
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Exclusion criteria
Charts were excluded if the diagnosis code was not one of the ICD-9 codes in the
inclusion criteria, there was no additional evidence in the chart indicating de Quervain's
tenosynovitis, the chart was assigned a new diagnosis (not related to de Quervain's tenosynovitis)
during the course of treatment, the individual was not at least 18 years old at the time of service,
the date of initial care was not between January 1, 2009 and January 1, 2013, the chart was not
an occupational therapy chart, or the case was not closed (Fig. 2). Out of a total of 403
electronic medical records, 245 were excluded due to a lack of evidence for de Quervain’s
tenosynovitis, 110 records were excluded because they were not occupational therapy records,
and 6 records were excluded because the individual was not at least 18 years old at the time of
service. This left a total of 42 records (Figs. 1 and 2).

Fig. 1. De Quervain’s tenosynovitis decision algorithm.
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Fig. 2. Chart determination algorithm.
Equipment and instruments
Treatment effectiveness was determined by a clinically significant improvement on the
QuickDASH and the NPRS.10,11 The QuickDASH is a short, reliable, and valid measure of
physical function that pertains to upper-limb musculoskeletal disorders and was adapted from the
Disabilities of the Arm, Shoulder, and Hand Outcome Measure.11,19,20 Only one study to date has
assessed the minimum clinically important difference to mark significant improvement from
clients’ baseline QuickDASH scores.21 A change exceeding eight points indicates a significant
rate of improvement. The NPRS was used in the present study to identify the level of pain in
individuals with de Quervain’s tenosynovitis. The NPRS has been deemed reliable and valid.2
Research indicates that a reduction of approximately two points or approximately 30% from the
initial pain rating represents a clinically significant improvement.23,24
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Procedure
Data management. Data was retrieved from electronic medical records and entered into
the password-protected Excel Extraction Tool Spreadsheet, which was available only to the
researchers. Any electronic transmission of identifiable data was performed over a secure server
to IRB-approved study personnel. Only de-identified data was shared with other members of the
research team who were not involved in the data collection process.
Provisions to maintain confidentiality. Electronic data were password protected on a
secure drive only accessible at the healthcare organization. Dates of service were converted to
whole numbers, with the initial visit considered Day 0, in the Excel Extraction Tool Spreadsheet.
These whole numbers were used for statistical analysis. De-identified electronic data was stored
indefinitely for future reference. Identifiable electronic data, including medical record numbers,
names, dates of birth, and other identifiable information, were deleted from the data set when all
analyses and publications were complete.
Statistical analysis. Statistical analysis of de-identified data was performed by the
researchers and reviewed by an epidemiologist. Data was analyzed with SPSS 20. Descriptive
statistics were obtained for all data collected. Chi-squared analysis was performed to determine
which treatments had a statistically significant difference on the NPRS and the QuickDASH. The
QuickDASH and NPRS scores for current level of pain considered in this analysis included those
taken at intake and discharge.
Results
Of the 42 charts selected, there were 32 females (76.2%), 10 males (23.8%), and patients’
ages ranged from 19 to 63 years of age, with a mean age of 39.19 years of age (standard
deviation of 12.74). Thirty-five patients were right hand dominant; however diagnosis frequency
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was similar between right and left sides, with a diagnosis of left de Quervain’s tenosynovitis for
15 patients (35.7%), right for 20 patients (47.6%), and bilateral for 7 patients (16.7%). Patients
sought treatment between two and 225 days following the onset of symptoms, with a mean of 75
days (standard deviation of 65.73). The mechanism of injury was classified as either sudden
onset, such as following a fall, a gradual onset, such as a repetitive stress injury from work, or
pregnancy-related onset. Five patients (13.5%) reported sudden onset, 31 (83.8%) patients
reported gradual onset, and one subject (2.7%) reported pregnancy-related onset. Symptoms
reported by patients were classified into the following categories: pain (83.3%),
catching/popping (4.8%), paresthesias (23.8%), swelling (4.8%), weakness (11.9%), spasms
(4.8%), and stiffness (2.4%). These categories were not mutually exclusive as patients may have
experienced multiple symptoms (Table 1).
Table 1
Descriptive statistics for the sample and treatments received
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Fifteen patients (35.7%) reported the use of non-steroidal anti-inflammatory drugs
(NSAIDs). There were a variety of co-morbid conditions recorded in the charts; however those
relevant to the de Quervain’s tenosynovitis diagnosis include arthritis (7.1%), CMC arthritis
(9.6%), previous upper extremity fracture (2.4%), and carpal tunnel syndrome (2.4%). Pertinent
surgical history of patients included unspecified hand/wrist surgery (4.8%), carpal tunnel
syndrome release (2.4%), de Quervain’s tenosynovitis corrective surgery (2.4%), and unspecified
shoulder surgery (4.8%) (Table 2).
Table 2
Descriptive statistics for the sample

At the time of treatment, 35 patients (94.6%) were employed and two patients (5.4%)
were students; employment information was not available for five patients. Patients reported
activity limitations in both activities of daily living (52.4%) and instrumental activities of daily
living (57.1%) (Table 3).
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Table 3
Descriptive statistics for the sample

The five conservative treatments used most frequently by hand/occupational therapists at
the healthcare organization were selected to be analyzed in greater detail. These treatments
included therapeutic pulsed ultrasound, iontophoresis with dexamethasone, fluidotherapy,
manual therapy, and activity modification training.
Thirty-two patients (76.2%) received therapeutic pulsed ultrasound at some point during
the course of treatment. Three out of the 32 patients received only 20% pulsed ultrasound, two
out of the 32 patients received both 20% and 50% pulsed ultrasound, and 27 out of the 32
patients received only 50% pulsed ultrasound. The overall range for therapeutic pulsed
ultrasound frequencies was 0.95-2.15 w/cm2; however, the majority (87.5%) of frequencies
ranged between 1.0-1.5 w/cm2. Approximately 68% of patients treated with therapeutic pulsed
ultrasound showed a clinically significant improvement on the QuickDASH; however, this was
not statistically significant (p= 0.804). Contrary to the QuickDASH, approximately 44% patients
who received pulsed ultrasound showed a clinically significant improvement for NPRS current
level of pain and this improvement was statistically significant (p= 0.046) (Tables 4, 5, 6, 7, and
8).
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Thirty-one patients (73.8%) received iontophoresis with dexamethasone (either with a
14-hour patch or in-clinic delivery methods) at some point during the course of treatment.
Approximately 95% of patients who received iontophoresis showed a clinically significant
improvement on the QuickDASH; this difference was also statistically significant (p= 0.028).
Approximately 89% of patients who received iontophoresis showed a clinically significant
improvement for NPRS current level of pain and this improvement was not statistically
significant (p= 0.186) (Tables 4, 5, 6, 7, and 8).
Seventeen patients (40.5%) received fluidotherapy at some point during the course of
treatment. However, there was not a clinically or statistically significant difference on the
QuickDASH (p= 0.643) or the NPRS (p= 0.143) (Table 4).
Thirty-two patients (76.2%) received manual therapy at some point during the course of
treatment. Types of manual therapy included cross friction massage, transverse friction massage,
and soft-tissue massage. Approximately 79% of patients who received manual therapy showed a
clinically significant improvement on the QuickDASH; however, this was not statistically
significant (p= 0.698). Approximately 78% of patients who received manual therapy showed a
clinically significant improvement for NPRS current level of pain and this improvement was not
statistically significant (p= 0.778) (Tables 4, 5, 6, 7, and 8).
Twenty-six (61.9%) patients received activity modification training at some point during
the course of treatment. Approximately 63% of patients who received activity modification
training showed a clinically significant improvement on the QuickDASH; however, this was not
statistically significant (p= 0.282). Approximately 67% of patients who received activity
modification training showed a clinically significant improvement for NPRS current level of pain
and this improvement was not statistically significant (p= 0.837) (Tables 4, 5, 6, 7, and 8).
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Conservative treatments utilized
Frequency Valid Percent (%)

Measure
Ultrasound
Yes
No

32
10

76.2
23.8

Yes
No

31
11

73.8
26.2

Yes
No

17
25

40.5
59.5

Yes
No
Activity Modification
Yes
No

32
10

76.2
23.8

26
16

61.9
38.1

Iontophoresis

Fluidotherapy

Manual Therapy

Table 5
Statistically significant response to treatment as determined by the QuickDASH
Treatment
Iontophoresis
Ultrasound
Fluidotherapy
Manual Therapy
Activity Modification

P-value
0.028
0.804
0.643
0.698
0.282

Table 6
Statistically significant response to treatment as determined by the NPRS for current pain
Treatment
Ultrasound
Iontophoresis
Fluidotherapy
Manual Therapy
Activity Modification

P-value
0.046
0.186
0.143
0.778
0.837
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Table 7
Clinically significant response to treatment as determined by the QuickDASH (n=30)
Treatment
Iontophoresis
Manual Therapy
Ultrasound
Activity Modification
Fluidotherapy

Percent clinically
significant improvement
QuickDASH (%)
94.7
78.9
68.4
63.2
36.8

Count
18
15
13
12
7

Table 8
Clinically significant response to treatment as determined by the NPRS for current pain (n=26)

Treatment
Iontophoresis
Manual Therapy
Activity Modification
Ultrasound
Fluidotherapy

Percent clinically
significant improvement
NPRS current pain(%)
88.9
77.8
66.7
44.4
44.4

Count
8
7
6
4
4

Discussion
This study examined five conservative occupational therapy treatments in relation to
clinical outcomes on the QuickDASH and the NPRS. According to the literature review, a
change exceeding eight points indicates a clinically significant difference on the QuickDASH,
while a reduction of approximately two points from the initial pain rating represents a clinically
significant improvement on the NPRS.23,24 For the present study, the clinically significant
improvement on the QuickDASH from the initial visit to discharge ranged from 9.09 to 81.73.
The clinically significant improvement on the NRPS ranged from 2 to 6 points. Among other
findings, the present study identified two statistically significant treatment methods:
iontophoresis with dexamethasone and therapeutic pulsed (20% or 50%) ultrasound (1.0 -1.5
w/cm2).
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Primary findings
Iontophoresis. The patients who received iontophoresis with dexamethasone
demonstrated a clinically and statistically significant improvement on the QuickDASH. Both the
patch applied in-clinic and worn at home for 14 hours, as well as in-clinic delivery methods with
a 40mA/min dosage were utilized. This finding may be important for therapists treating de
Quervain’s tenosynovitis because of the significant improvement on the QuickDASH.
Ultrasound. The patients who received therapeutic pulsed ultrasound demonstrated a
clinically and statistically significant improvement on the NPRS for current levels of pain. Only
therapeutic pulsed (20% or 50%) ultrasound was utilized, and frequencies between 1.0 and 1.5
w/cm2 were employed with 87.5% of the patients. Pain management is a key role for
hand/occupational therapists and is necessary for the patient to return to daily occupations.3,6
This finding is important for occupational therapists in that ultrasound appeared to play a role in
clinically and statistically significant pain reduction which can facilitate participation in daily
activities.
Manual therapy. Thirty-two of the 42 patients received manual therapy at some point
during the course of treatment. While there was not a statistically significant difference found,
79% of patients who received manual therapy showed a clinically significant improvement on
the QuickDASH and 78% of patients who received manual therapy showed a clinically
significant improvement for NPRS current level of pain. These findings indicate that
occupational therapists frequently treat de Quervain’s tenosynovitis with manual therapy, and
further research is needed to determine (a) its effectiveness and (b) which specific type of
manual therapy treatment (i.e. soft tissue massage, cross friction massage, or transverse friction
massage) is the most effective.
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Activity modification. Activity modification is an area of practice frequently targeted by
hand/occupational therapists.25 In the present study, a large number of patients (63%) who
received activity modification training showed a clinically significant improvement on the
QuickDASH and 67% of patients who received activity modification training showed a clinically
significant improvement for NPRS current level of pain; however, no statistical significance was
found. Effectiveness of activity modification is an important consideration for further research.
Secondary findings
According to the literature, a thumb spica orthosis is primarily utilized to provide rest for
the APL and EPB tendons. 3,6 In the present study, the majority of patients were provided with a
pre-fabricated orthosis by their physician prior to beginning treatment. Few patients received
orthotics during the course of treatment. Of the small number (9) of orthotics distributed, the
majority of patients (80%) were fitted with a neoprene thumb spica orthosis, while the remaining
patients were provided with a custom fabricated thermoplastic thumb spica orthosis. The
flexibility of neoprene orthotics allows for some movement of the thumb, which may not
completely rest the APL and EPB tendons.26 Additionally, no information regarding compliance
was documented following distribution of the orthoses, and, as a result, it is difficult to determine
the effectiveness of the use of orthoses with the present study. Further research is needed,
especially in the area of rigid orthoses and de Quervain’s tenosynovitis.
Strengths and limitations
While the researchers are current graduate occupational therapy students, they were
closely mentored by academic research advisors and other experienced clinicians. Although data
was collected by the three researchers, the decision algorithm ensured a consistent process to
accurately include charts based on a diagnosis of de Quervain’s tenosynovitis. Furthermore, valid

TREATMENTS FOR DE QUERVAIN’S TENOSYNOVITIS

17

and reliable outcome tools (the QuickDash and the NPRS) were utilized. Despite the small
sample size, clinical and statistical significance were demonstrated in the improvement of pain
symptoms and function.
The limitations of this study are inherent to the retrospective design and small sample
size. Information regarding discharge was limited, there were notable differences in clinician
documentation, and information related to overall subject treatment compliance, which was
unavailable in many cases. Another limitation to consider was the patients’ use of NSAIDs.
Fifteen of the 42 patients reported the use of NSAIDs at intake. It was unclear if NSAID use
continued or was later initiated during the course of treatment, or if NSAID use was a
contributing factor to improvement. Finally, the sample was selected from a single healthcare
organization and therefore may not be generalizable.
Conclusion
The clinical contribution of the present study was demonstrating the effectiveness of two
conservative treatment methods for de Quervain’s tenosynovitis. Iontophoresis with
dexamethasone was shown to be both clinically and statistically significant as evidenced by
improvement on QuickDASH scores, while therapeutic pulsed (20 and/or 50%) ultrasound (1.01.5 w/cm2) was shown to be both clinically and statistically significant as evidenced by
improvement on NPRS current level of pain scores. This may demonstrate the efficacy of
iontophoresis with dexamethasone and pulsed (20% or 50%) ultrasound (1.0 –1.5 w/cm2) in the
treatment of de Quervain’s tenosynovitis. Further research is needed that focuses on
iontophoresis administration (i.e. 14-hour patch versus in-clinic delivery methods and
corresponding dosages), activity modification, manual therapy, and the use of orthotics. In
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addition, studies with larger sample sizes that include information regarding patient compliance
with each treatment is recommended.
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